Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Juyuan Biotechnology is a leading Chinese biotechnology company focused on the development and manufacture of recombinant collagen through synthetic biology. As a key subsidiary of Giant Biogene, the company utilizes proprietary high-density fermentation and purification technologies to produce bioactive recombinant human-like collagen. Its portfolio includes raw materials and finished products for medical aesthetics, wound healing, and functional skincare. The company's technology platform enables the production of collagen with high biocompatibility and low immunogenicity, positioning it as a major player in the regenerative medicine and dermatology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Juyuan Biotechnology.